PRGO (STOCKS)
PERRIGO COMPANY PLC
$11.290000
+0.430000 (+3.96%)
Prev close: $10.860000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Patrick Lockwood-Taylor
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,555.44M
- Employees
- 8,379
- P/E (TTM)
- -1.10
- P/B (TTM)
- 0.51
- Dividend Yield
- 1,068.14%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $3.70B |
| Benefits Costs and Expenses | $3.33B |
| Cost Of Revenue | $2.35B |
| Costs And Expenses | $3.33B |
| Gross Profit | $1.35B |
| Operating Expenses | $710.36M |
| Selling, General, and Administrative Expenses | $464.77M |
| Research and Development | $120.11M |
| Operating Income/Loss | $640.66M |
| Income/Loss Before Equity Method Investments | $624.22M |
| Income/Loss From Continuing Operations After Tax | $290.86M |
| Income/Loss From Continuing Operations Before Tax | $424.41M |
| Income Tax Expense/Benefit | $176.50M |
| Income Tax Expense/Benefit, Deferred | -$5.40M |
| Net Income/Loss | $338.02M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$109.70M |
| Net Income/Loss Attributable To Parent | $447.72M |
| Net Income/Loss Available To Common Stockholders, Basic | $447.72M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $4.76 |
| Diluted Earnings Per Share | $4.74 |
| Basic Average Shares | 376,103,000 |
| Diluted Average Shares | 378,250,000 |
| Assets | $5.51B |
| Current Assets | $2.37B |
| Inventory | $721.40M |
| Other Current Assets | $1.65B |
| Noncurrent Assets | $3.14B |
| Fixed Assets | $691.10M |
| Other Non-current Assets | $2.45B |
| Liabilities | $3.04B |
| Current Liabilities | $743.50M |
| Accounts Payable | $303.50M |
| Wages | $75.60M |
| Other Current Liabilities | $364.40M |
| Noncurrent Liabilities | $2.30B |
| Equity | $2.47B |
| Equity Attributable To Noncontrolling Interest | $700.00K |
| Equity Attributable To Parent | $2.47B |
| Liabilities And Equity | $5.51B |
| Net Cash Flow From Operating Activities | $607.60M |
| Net Cash Flow From Operating Activities, Continuing | $643.50M |
| Net Cash Flow From Investing Activities | -$968.80M |
| Net Cash Flow From Investing Activities, Continuing | -$968.80M |
| Net Cash Flow From Financing Activities | $548.60M |
| Net Cash Flow From Financing Activities, Continuing | $548.60M |
| Exchange Gains/Losses | -$2.80M |
| Net Cash Flow | $184.60M |
| Net Cash Flow, Continuing | $187.40M |
| Comprehensive Income/Loss | $505.88M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $505.88M |
| Other Comprehensive Income/Loss | $394.48M |
| Other Comprehensive Income/Loss Attributable To Parent | $58.06M |